News
MRFF backs UQ epilepsy research
UQ researchers have received $4.1 million from the Medical Research Future Fund to advance their research into epilepsy treatments made from spider venom proteins.
Led by Professor Ernst Wolvetang, the project aims to prove the safety and efficacy of venom-based drugs by testing them on lab-grown brain and heart organoids grown from the cells of epilepsy patients.
The research aims to pave the way for human clinical trials and to establish organoids as a tool that can be used to test experimental treatments and therapies.
The funding has been provided through the MRFF’s Stem Cell Therapies grant scheme.
Media contactUQ Communications
communications@uq.edu.au
+61 429 056 139
Related articles
Analysis
Australia needs doctors – so why are hundreds of qualified international physicians unable to work?
Qualified doctors who could be working in clinics and hospitals are instead driving Ubers. Here are some practical ways to fix that.
27 November 2025
Greater attention needed on community service workforce
Lack of job security and poor career progression are discouraging Australians from working in the community care sector, a report by UQ researchers has found.
26 November 2025